← Eichor
Condition: Eskd Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Eskd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
Phase 1 · 1 location(s) · CSL Behring · NCT07619820DIALysis With EXpanded Solute Removal
NA · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT06660277Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD
NA · 1 location(s) · University of Illinois at Chicago · NCT07014111Comparisons Of Biochemical And Clinical Outcomes Of Hemodialysis Patients Treated With Middle Cut-Off Dialyzers Versus H
Phase N/A · 1 location(s) · Arbor Research Collaborative for Health · NCT07561424A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With An
Phase 3 · 1 location(s) · Kind Pharmaceuticals LLC · NCT07494409Preoperative Hemodialysis Timing in Patients With End-Stage Kidney Disease: The POD-ESKD Pilot Trial
NA · 1 location(s) · Stanford University · NCT07339202Duke APOL1 Research Biorepository
Phase N/A · 1 location(s) · Duke University · NCT04160507Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (
Phase 2/Phase 3 · 548 location(s) · CSL Behring · NCT05485961Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
NA · 5 location(s) · Diality Inc. · NCT06613568Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
NA · 115 location(s) · The University of Queensland · NCT03573089Comparing Conventional Continuous Ambulatory Peritoneal Dialysis Prescription (C-CAPD) With Modified-CAPD (M-CAPD) Presc
NA · 1 location(s) · National University Health System, Singapore · NCT07134595A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
Phase 3 · 42 location(s) · Alebund Pharmaceuticals · NCT06933472Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Contr
NA · 1 location(s) · Navamindradhiraj University · NCT06989892Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.
Phase N/A · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT06474169
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.